ASC Stock Recent News

Recently, Zacks.com users have been paying close attention to Ardmore Shipping (ASC). This makes it worthwhile to examine what the stock has in store.

Ardmore Shipping Corporation (NYSE:ASC ) Q1 2025 Earnings Conference Call May 7, 2025 10:00 AM ET Company Participants Gernot Ruppelt - CEO Bart Kelleher - President and CFO Conference Call Participants Jon Chappell - Evercore ISI Omar Nokta - Jefferies Operator Good morning, ladies and gentlemen, and welcome to Ardmore Shipping's First Quarter 2025 Earnings Conference Call. Today's call is being recorded, and an audio webcast and presentation are available in the Investor Relations section of the company's website, ardmoreshipping.com.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Ardmore Shipping (ASC) came out with quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.92 per share a year ago.

HAMILTON, Bermuda , May 7, 2025 /PRNewswire/ -- Ardmore Shipping Corporation (NYSE: ASC) ("Ardmore", the "Company" or "we") today announced results for the three months ended March 31, 2025. Highlights and Recent Activity Reported Adjusted earnings and net income attributable to common stockholders of $5.6 million for the three months ended March 31, 2025, or $0.14 earnings per basic and diluted share, compared to Adjusted earnings and net income attributable to common stockholders of $38.4 million, or $0.93 earnings per basic share and $0.92 earnings per diluted share for the three months ended March 31, 2024.

HONG KONG , May 6, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") announces oral and poster presentations on preliminary studies of ASC47, an adipose-targeted, muscle-preserving weight loss drug candidate for obesity, will be presented at the 32nd European Congress On Obesity (ECO 2025) in Malaga, Spain. Oral Presentation Details Title: ASC47, An Adipose-Targeted, Muscle-Preserving Weight Loss Drug Candidate For Obesity, Demonstrated Significant Weight Loss And Preserved Muscle In DIO Mice Abstract Category/Topi c : Obesity Management and Intervention » Emerging treatments Abstract Number: 0254 Session: T1 Abstract Session: Novel Drugs.

Ardmore Shipping (ASC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ZyVersa's IC 100 blocked microglial NLRP1 inflammasome activation and reduced alpha-synuclein accumulation supporting its potential for Parkinson's Disease

The latest trading day saw Ardmore Shipping (ASC) settling at $9.55, representing a -0.31% change from its previous close.

Ardmore Shipping (ASC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.